Triall is building the world’s first blockchain-enabled clinical research ecosystem, serving and connecting all who are involved in carrying out clinical trials. The Triall ecosystem promotes trust, research data integrity, and auditability throughout all phases of clinical development, utilizing the strengths of blockchain technology where these truly add value.
Our aim is to tackle many of the persisting issues that make medical innovation an overly complex, lengthy, and resource-inefficient undertaking.
Experienced CEO in the pharmaceutical and clinical research domain, with extensive experience in managing international clinical trials (phase I-IV). Fully geared towards making innovative treatments accessible to those in need.
Experienced blockchain developer and serial entrepreneur with over 15 years of experience in various CTO roles. Guide of the Factom Blockchain, responsible for its full decentralization.
Academic entrepreneur, project manager and consultant. Co-founder of two successful Life Sciences management consultancies. Holds a cum laude PhD in science commercialization.
Corporate lawyer and deal-maker with extensive experience as legal counsel in the pharmaceutical and health care industries. Headed the legal department of Erasmus University Medical Center.
PhD candidate, holding degrees in Biomedical Sciences and Entrepreneurship. Has been designing real-life use cases for blockchain technology in clinical operations and data management over the past years.
PhD candidate and consultant in medical innovation management with degrees in Biomedical Sciences (Health Technology Assessment) and Entrepreneurship. Passionate (self-taught) graphic designer with experience in commercial web- and UX design projects for over 12 years.
Project manager and clinical research scientist, operating at the interface between industry and academia. Experienced in clinical operations, medical writing and microbiota R&D. Dedicated to translating the benefits of blockchain technology to end-user functionalities in the clinical trial domain.
Immunologist, Full Professor and sequential entrepreneur. Co-founded over 20 companies in the Life Sciences. Government and boardroom advisor on biomedical innovation and entrepreneurship.
Full Professor of Primary Care Medicine and Strategic Chair of eHealth Applications in Disease Management at Leiden University Medical Center (LUMC). Founder and Director of the National eHealth Living Lab (NeLL). Authored 190+ peer-reviewed papers on eHealth, mHealth, and disease management. Raised €30M+ in funding over the past 15 years.
Professor (Health care consumers & Experienced health) at the Center for Supply Chain Management and Marketing, Nyenrode Business University. International expert in health consumer behavior, methodology and health care innovation. Working for Janssen (pharmaceutical co. of Johnson & Johnson) from 2000 onward as innovation manager.
All-round clinical operations and quality management specialist, with 25+ years in pharmaceutical R&D and clinical trial quality management. Compliance expert in FDA, EMA, and ICH-GCP laws and regulations.
Head clinical operations, with 10+ years in managing international clinical trials (phase I-IV) across therapeutic areas. Currently leading CEPI and Horizon2020 clinical trials.
Software and IT entrepreneur, with 20+ years in document management solutions. Founder of Magellan Benelux (sold to OpenText) and co-founder of Sphereon, optimizing document processing with enterprise-grade microservices architectures, blockchain and AI. Invited speaker on blockchain-enabled document management solutions across the globe.
Director business development and recruitment, with 15+ years in clinical research within the pharmaceutical and contract research services industry. In 2010 he changed his career path to providing staffing solutions for Life Sciences companies and CRO’s.
We’re proud to present you the Triall whitepaper. It covers over 40 pages of detailed information on our vision and plans for a blockchain-enabled clinical trial ecosystem, including: